Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.15 -0.09 (-2.12%)
At close: Nov 10, 2026 · 4:00 PM EST

Aclaris Therapeutics (ACRS) Liabilities and Shareholders Equity (2014 - 2026)

Updated

Analysis

Aclaris Therapeutics (ACRS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Aclaris Therapeutics 625.92 Mn 223.91 Mn 1.29 Mn 216.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 216.16 Mn
Jun 30, 2026 179.69 Mn
Mar 31, 2026 198.72 Mn
Dec 31, 2025 160.46 Mn
Sep 30, 2025 175.53 Mn
Jun 30, 2025 189.15 Mn
Mar 31, 2025 198.09 Mn
Dec 31, 2024 220.33 Mn
Sep 30, 2024 182.39 Mn
Jun 30, 2024 161.07 Mn
Mar 31, 2024 174.07 Mn
Dec 31, 2023 197.41 Mn
Sep 30, 2023 218.35 Mn
Jun 30, 2023 235.65 Mn
Mar 31, 2023 229.71 Mn
Dec 31, 2022 254.60 Mn
Sep 30, 2022 267.63 Mn
Jun 30, 2022 277.98 Mn
Mar 31, 2022 226.53 Mn
Dec 31, 2021 251.21 Mn
API Access

Aclaris Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ACRS&period=max&api_key=YOUR_API_KEY